Canada authorizes Mo-99 production at Darlington station

November 12, 2021, 9:30AMNuclear News
Darlington nuclear power plant. (Photo: OPG)

The Canadian Nuclear Safety Commission (CNSC) has amended Ontario Power Generation’s (OPG) operating license for its Darlington nuclear power station near Clarington, Ontario, allowing the company to produce the medical radioisotope molybdenum-99 using Darlington’s Unit 2 CANDU reactor. OPG subsidiary Laurentis Energy Partners, in conjunction with BWXT Medical, is leading the program to produce Mo-99 at Darlington.

To continue reading, log in or create a free account!

Related Articles

Taking aim at disease

Radioisotopes target cancer, improve imaging, and have myriad other medical uses

February 16, 2024, 3:02PMNuclear NewsKristi Nelson Bumpus

On August 2, 1946, 1 millicurie of the isotope carbon-14 left Oak Ridge National Laboratory, bound for the Barnard Free Skin and Cancer Hospital in St. Louis, Mo.That tiny amount of the...

Young Members Group shines at YPC

January 9, 2024, 4:48PMNuclear News

A big thank-you to the American Nuclear Society Young Members Group for all it accomplished at the Young Professionals Congress (YPC) and President’s Special Session at the 2023 ANS Winter...

National lab partnerships speed nuclear deployment

December 15, 2023, 4:56PMNuclear NewsDonna Kemp Spangler and Joel Hiller

“The tools of the academic designer are a piece of paper and a pencil with an eraser. If a mistake is made, it can always be erased and changed. If the practical-reactor designer errs, he...